Revenue FY2025
$3.0M
Net Income
$(143.0M)
EPS (Basic)
$-2.66
Net Margin
-5026.0%
ROE
-42.2%
Total Equity
$340.0M
Shares Out
55M
Upstream Bio, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 1 fund in our universe
FundPosition Value% of AUMQoQ ChgWeight
OrbiMed Advisors
OrbiMed Advisors
$39.4M
0.2%
—
Insider Transactions
Reading stored insider transactions…